Artigos
2020
Coelho M, Raposo L, Goodfellow BJ, Atzori L, Jones J, Manadas B
The Potential of Metabolomics in the Diagnosis of Thyroid Cancer.
Int J Mol Sci, 2020 Jul 24;21(15):E5272. doi: 10.3390/ijms21155272.
2019
Metabolic Syndrome, Thyroid Function and Autoimmunity - The PORMETS Study.
Endocr Metab Immune Disord Drug Targets, 2019;19(1):75-83. doi: 10.2174/1871530318666180801125258.
2018
Adiposity cut-off points for cardiovascular disease and diabetes risk in the Portuguese population: The PORMETS study.
PLoS One, 2018 Jan 29;13(1):e0191641. doi: 10.1371/journal.pone.0191641. eCollection 2018.
2018
Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors.
Cancers (Basel), 2018 Aug 27;10(9). pii: E293. doi: 10.3390/cancers10090293.
2017
The prevalence of the metabolic syndrome in Portugal: the PORMETS study.
BMC Public Health, 2017 Jun 8;17(1):555. doi: 10.1186/s12889-017-4471-9.
2017
Trends in thyroid cancer incidence and mortality in Portugal.
Eur J Cancer Prev, 2017 Mar;26(2):135-143. doi: 10.1097/CEJ.0000000000000229.
2017
Vitamin D, parathyroid hormone and metabolic syndrome - the PORMETS study.
BMC Endocr Disord, 2017 Nov 17;17(1):71. doi: 10.1186/s12902-017-0221-3.
2013
The development and validation of the Portuguese risk score for detecting type 2 diabetes and impaired fasting glucose
Prim Care Diabetes, 2013 Apr;7(1):11-8. doi: 10.1016/j.pcd.2013.01.003. Epub 2013 Jan 26.